MGEE 45.42 Mge Energy Inc $MGEE Hit a 52 week high of 46.19

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
MGEE 45.42 Mge Energy Inc $MGEE Hit a 52 week high of 46.19 Closing the day 09:40 at 45.42 -0.89 -1.92% With a day low of 45.42 and a total volume of 1,660.

MGEE Recent Posts: http://investorshangout.com/Mge-Energy-Inc-MGEE-54750/

MGEE Mge Energy Inc Recent Headline News

MGE Energy Issues Third-Quarter Financial Update
Business Wire - Fri Nov 07, 11:19AM CST
MGE Energy, Inc. (Nasdaq: MGEE) today issued its third-quarter 2014 financial update presentation.
MGEE: 45.34 (-0.97)

MGE Energy Has Returned 13.1% Since SmarTrend Recommendation (MGEE)
Comtex SmarTrend(R) - Fri Nov 07, 9:58AM CST
SmarTrend identified an Uptrend for MGE Energy (NASDAQ:MGEE) on October 13th, 2014 at $39.48. In approximately 4 weeks, MGE Energy has returned 13.06% as of today's recent price of $44.63.
MGEE: 45.34 (-0.97)

MGE Energy reports Q3 profit
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 5:22PM CST

MGEE: 45.34 (-0.97)

MGE Energy Reports Third-Quarter Earnings
Business Wire - Thu Nov 06, 3:32PM CST
MGE Energy, Inc. (Nasdaq: MGEE) today reported earnings for the three months ended Sept. 30, 2014, of $23.3 million, or 67 cents per share, compared to $24.4 million, or 70 cents per share, for the same period in the prior year. Average shares outstanding and per share amounts for all periods presented reflect the three-for-two stock split declared on Dec. 20, 2013, effective in the form of a stock dividend distributed on Feb. 7, 2014.
MGEE: 45.34 (-0.97)

MGE Energy Up 13.9% Since SmarTrend Uptrend Call (MGEE)
Comtex SmarTrend(R) - Fri Oct 31, 9:37AM CDT
SmarTrend identified an Uptrend for MGE Energy (NASDAQ:MGEE) on October 13th, 2014 at $39.48. In approximately 3 weeks, MGE Energy has returned 13.87% as of today's recent price of $44.95.
MGEE: 45.34 (-0.97)

How Did High-Yield Dividend Champions Do During The Great Recession? Part 2
Robert Mattei - at Seeking Alpha - Wed Oct 29, 1:34PM CDT

WGL: 47.39 (-0.57), GE: 26.52 (+0.14), HSY: 96.40 (-0.07), MGEE: 45.34 (-0.97), ED: 62.28 (-1.18), MTB: 125.34 (+0.49), CB: 101.50 (+0.01), USBI: 8.85 (+0.20), BOH: 60.45 (+0.54), T: 35.36 (+0.26), CINF: 51.35 (+0.17), MYE: 15.59 (-0.09), VVC: 45.29 (-0.57), AVY: 48.00 (+0.04), TEG: 71.48 (-1.37), CBSH: 46.32 (+0.33), ORI: 15.08 (+0.15), STT: 77.22 (-0.46), PBI: 24.60 (-0.15), SVU: 8.87 (+0.20), PFE: 30.52 (+0.20), LEG: 41.25 (-0.05), FRT: 132.06 (-1.62), LLY: 67.64 (-0.21), EV: 41.56 (-0.17), MAS: 23.15 (-0.07), LZB: 23.51 (-0.03), RLI: 49.04 (-0.10), PEBO: 26.08 (+0.34), GCI: 30.90 (+0.07), TFX: 114.49 (+0.16), AFL: 59.18 (+0.14), CTL: 40.21 (+0.24), OTTR: 30.18 (-0.96), JCI: 49.41 (-0.17)

How Top 5-Star Dividend Dogs Earned Their Stars
Fredrik Arnold - at Seeking Alpha - Fri Oct 24, 12:19PM CDT

WGL: 47.39 (-0.57), KO: 42.82 (+0.31), SAFT: 60.42 (-0.28), WR: 38.76 (-0.68), HCN: 70.79 (-0.05), MGEE: 45.34 (-0.97), UHT: 48.18 (-0.01), DLR: 68.46 (+0.01), ED: 62.28 (-1.18), GAS: 52.01 (-1.26), SYY: 38.86 (+0.34), NNN: 38.37 (+0.06), IRM: 37.99 (+0.16), LEG: 41.25 (-0.05), KMP: 94.51 (+0.18), FRT: 132.06 (-1.62), MO: 49.26 (-0.02), PEP: 97.28 (+0.58), DFT: 31.31 (-0.09), VVC: 45.29 (-0.57), PPL: 35.89 (-0.68), PLOW: 23.04 (+0.07), PG: 89.62 (-0.05), CWT: 25.41 (-0.11), VGR: 22.00 (+0.08)

From 5 To 58 Years 5-Star Dividend Dogs Hiked Annual Dividends
Fredrik Arnold - at Seeking Alpha - Thu Oct 23, 2:50PM CDT

KO: 42.82 (+0.31), SAFT: 60.42 (-0.28), HCN: 70.79 (-0.05), MGEE: 45.34 (-0.97), UHT: 48.18 (-0.01), DLR: 68.46 (+0.01), ED: 62.28 (-1.18), SYY: 38.86 (+0.34), NNN: 38.37 (+0.06), IRM: 37.99 (+0.16), LEG: 41.25 (-0.05), KMP: 94.51 (+0.18), FRT: 132.06 (-1.62), MO: 49.26 (-0.02), PEP: 97.28 (+0.58), DFT: 31.31 (-0.09), VVC: 45.29 (-0.57), PG: 89.62 (-0.05), CWT: 25.41 (-0.11), VGR: 22.00 (+0.08)

MGE Energy Issues October 2014 'Inside View'
Business Wire - Thu Oct 16, 10:24AM CDT
MGE Energy, Inc. (Nasdaq: MGEE) today published its investor newsletter "Inside View" with the following topics:
MGEE: 45.34 (-0.97)

Duke Energy Renewable Services lands O&M agreements for Rosiere and Lincoln wind farms
M2 - Mon Oct 13, 3:52AM CDT
Duke Energy Renewable Services has signed five-year service agreements for two wind projects in Kewaunee County, Wis., owned by Madison Gas and Electric and Wisconsin Public Service.
MGEE: 45.34 (-0.97), DUK: 80.07 (-2.59), TEG: 71.48 (-1.37)

MGE Energy Issues September 2014 'Interim Report'
Business Wire - Mon Sep 15, 9:04AM CDT
MGE Energy, Inc. (Nasdaq: MGEE) today published its investor newsletter "Interim Report" with the following topics:
MGEE: 45.34 (-0.97)

MGE Energy Increases Dividend for 39th Consecutive Year
Business Wire - Fri Aug 15, 12:43PM CDT
The board of directors of MGE Energy, Inc. (Nasdaq: MGEE) today increased the regular quarterly dividend rate by 4.0% to $0.2825 per share on the company's common stock. The dividend is payable Sept. 15, 2014, to shareholders of record Sept. 1, 2014. This increase raises the annual dividend rate by 4 cents from $1.09 per share to $1.13 per share.
MGEE: 45.34 (-0.97)

MGE Energy Issues Second-Quarter Financial Update
Business Wire - Thu Aug 07, 9:08AM CDT
MGE Energy, Inc. (Nasdaq: MGEE) today issued its second-quarter 2014 financial update presentation.
MGEE: 45.34 (-0.97)

MGE Energy Reports Second-Quarter Earnings
Business Wire - Wed Aug 06, 12:00PM CDT
MGE Energy, Inc. (Nasdaq: MGEE) today reported earnings for the three months ended June 30, 2014, of $14.1 million, or 41 cents per share, compared to $13.9 million, or 40 cents per share, for the same period in the prior year. Average shares outstanding and per share amounts for all periods presented reflect the three-for-two stock split declared on Dec. 20, 2013, effective in the form of a stock dividend distributed on Feb. 7, 2014.
MGEE: 45.34 (-0.97)

MGE Energy Issues June 2014 'Interim Report'
Business Wire - Fri Jun 13, 8:41AM CDT
MGE Energy, Inc. (Nasdaq: MGEE) today published its investor newsletter "Interim Report" with the following topics:
MGEE: 45.34 (-0.97)

MGE Energy Issues March 2014 'Interim Report'
Business Wire - Fri Mar 14, 9:20AM CDT
MGE Energy, Inc. (Nasdaq: MGEE) today published its investor newsletter "Interim Report" with the following topics:
MGEE: 45.34 (-0.97)

MGE Energy Issues Fourth-Quarter Financial Update
Business Wire - Fri Feb 28, 9:33AM CST
MGE Energy, Inc. (Nasdaq: MGEE) today published its fourth-quarter 2013 financial update presentation.
MGEE: 45.34 (-0.97)

Consumer Advisory - Children Upper Outerwear Hoodies and Jackets with Drawstrings
CNW Group - Fri Feb 21, 11:55AM CST
FGL Sports is voluntarily issuing this advisory to consumers who have purchased children and youth upper outerwear hoodies and jackets with a drawstring and/or toggle located at the hood/neck area.
MGEE: 45.34 (-0.97), CTC.TO: 220.00 (+0.25)

MGE Energy Inc. (MGEE) Stock Research Links

MGEE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 9

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 4

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 3

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 5

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 6

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 3

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 4

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading

Top 5 Most Recently Viewed Articles

Soleno Therapeutics Celebrates FDA Approval of VYKAT XR for PWS

Updated Category News Views 420

Soleno Therapeutics Announces FDA Approval for VYKAT XR Soleno Therapeutics, Inc. (NASDAQ: SLNO), a notable biopharmaceutical company, has made a significant announcement regarding the U.S. Food and Drug Administration (FDA) approval of VYKAT XR (diazoxide choline) extended-release tablets. This new treatment targets hyperphagia in individuals aged four and older...

Continue Reading
aTyr Pharma Faces Legal Challenges: Investors Urged to Act

Updated Category News Views 173

aTyr Pharma's Legal Situation and Its Implications Recent developments surrounding aTyr Pharma, Inc. (NASDAQ: ATYR) have caught the attention of investors, particularly as the company faces significant legal challenges. The situation arose from a steep decline in share value triggered by disappointing results from a key clinical trial. This decline, marked by an...

Continue Reading
Primo Brands Boosts Share Repurchase Program by $50 Million

Updated Category News Views 145

Primo Brands Boosts Share Repurchase Program Primo Brands Corporation (NYSE: PRMB) is excited to announce a significant increase in its share repurchase program. This decision, made by the Board of Directors, involves raising the repurchase authorization by $50 million, bringing the total program authorization to an impressive $300 million. This enhancement in the share...

Continue Reading
GOTRAX Partners with RSMG Select to Inspire Youth Movement

Updated Category News Views 83

GOTRAX Teams Up with RSMG Select for Youth Development GOTRAX has embarked on an inspiring journey through its partnership with RSMG Select, aimed at nurturing not just young athletes but the community at large. The collaboration has transformed the experience for youth participating in futsal, allowing for significant growth and empowerment beyond the typical sports...

Continue Reading
Zenas BioPharma Celebrates Major Milestones in Q3 2025

Updated Category News Views 245

Zenas BioPharma Celebrates Major Milestones in Q3 2025 - Obexelimab Phase 3 INDIGO trial topline results in Immunoglobulin G4-Related Disease (IgG4-RD) expected around year-end. - Reported highly positive 12-week primary endpoint results from Phase 2 MoonStone trial of obexelimab in Relapsing MS (RMS). - Secured development and commercialization rights for three...

Continue Reading